Signs & Symptoms

Symptoms of Perimenopause

Symptoms cluster into four physiological categories. Most women experience symptoms from multiple categories, and the pattern shifts as the transition progresses.

Symptom	What happens
Vasomotor
Hot Flashes	Sudden waves of intense heat, typically starting in the chest/neck and spreading upward, lasting 1 to 5 minutes. Frequency ranges from occasional to dozens per day.
Night Sweats	Nocturnal hot flashes that drench bedding and disrupt sleep architecture. A primary driver of perimenopausal insomnia and the daytime fatigue cascade that follows.
Heart Palpitations	Fluttering, racing or skipped beats, often during hot flashes or at night. Usually benign but should be evaluated to rule out other causes.
Genitourinary
Vaginal Dryness	Declining estrogen thins vaginal epithelium and reduces natural lubrication, causing dryness, itching and discomfort. Often begins quietly in late perimenopause and progresses without intervention.
Painful Intercourse (Dyspareunia)	Thinning vaginal tissue plus reduced elasticity causes friction-related pain.
Urinary Urgency & Frequency	Estrogen receptors line the bladder and urethra; their reduced stimulation causes urgency, frequency and sometimes urge incontinence. Often misdiagnosed as overactive bladder.
Recurrent UTIs	Vaginal pH rises as estrogen falls, depleting protective Lactobacillus and allowing pathogenic bacteria to colonize.
Psychological
Anxiety & Panic	New-onset anxiety in the 40s, especially without a clear external trigger, is common in perimenopause, but thyroid problems, heart rhythm problems and anxiety disorders still need to be ruled out.
Low Mood & Depression	In one cohort, major depression was two to four times more likely during perimenopause and early postmenopause than before¹⁰. Disrupted sleep adds to it. Often presents as irritability, tearfulness and loss of motivation rather than classic sadness.
Brain Fog & Memory Lapses	Word-finding difficulty, lost trains of thought and reduced multitasking capacity. Worsens with sleep deprivation.
Insomnia & Sleep Fragmentation	Trouble falling asleep, frequent awakening at 2 to 4 AM, and unrefreshing sleep. Night sweats are one cause. Often the most disruptive symptom in mid-perimenopause.
Long-Term Health Risks
Accelerated Bone Loss Begins	Estrogen restrains osteoclast (bone-resorbing) activity¹¹. Bone loss speeds up as estrogen falls and is fastest in the first 4 to 8 years after menopause⁵. Bone health is worth discussing at review appointments.
Rising Cardiovascular Risk	Much of estrogen's protection against heart attack and stroke is lost after menopause, while risk factors such as high cholesterol and blood pressure become more common in midlife⁵.
Insulin Resistance & Belly Fat	Body composition shifts: muscle mass declines, visceral (abdominal) fat increases, insulin sensitivity drops.

Treatment Comparison

Conventional and Holistic Treatment for Perimenopause

🌿 HOLISTIC

💊 CONVENTIONAL

🌿

Holistic / Functional Approach

Phytoestrogen-rich foods, adaptogens for stress, blood sugar balance, strength training

Symptom Reduction

Lifestyle changes may ease vasomotor symptoms; supplement trials are inconsistent and placebo response is high¹⁶

Key Interventions

Phytoestrogen-rich foods, magnesium for sleep, ashwagandha for stress, gut microbiome work, strength training

Timeline

Any sleep or symptom changes from lifestyle measures build over weeks to months; symptoms also fluctuate on their own through the transition

Advantage

Supports long-term metabolic and skeletal health

Full Holistic Approach Includes

Phytoestrogen-rich foods, flaxseed (2 tbsp/day ground), soy (tempeh, edamame, miso) and legumes. In trials, soy isoflavone supplements cut hot flash frequency by 20.6% more than placebo, red clover extract showed no significant effect in a Cochrane review and a small one in a 2026 meta-analysis, and the North American Menopause Society does not recommend soy for hot flashes¹⁷¹⁶, so eat these foods for general health rather than for hot flashes
Adaptogenic herbs, ashwagandha, rhodiola and maca, studied in small trials for stress, mood and libido; ashwagandha has been linked to rare liver injury and can affect thyroid levels, so check with your clinician first
Magnesium glycinate (300 to 400 mg/night), sometimes used for sleep, though a placebo-controlled trial found no effect on hot flashes¹⁸. The top of this range is above the 350 mg/day upper intake level for supplemental magnesium; above that, diarrhea is common. With kidney disease, take it only on your clinician's advice.
Omega-⁠3 EPA/DHA, not recommended for hot flashes: in trials it did not reduce them¹⁸
B-complex (especially B6, B12 and folate), contributes to neurotransmitter synthesis
Diverse fiber and fermented foods, for gut and heart health
Cruciferous vegetables daily, as part of a healthy diet
Blood sugar stabilization, protein + fiber + fat at every meal; minimize refined carbs and alcohol (alcohol is a major hot flash trigger)
Resistance training 3x/week + impact exercise 2x/week, builds bone density and muscle mass, both of which start declining now
Stress management, meditation, breathwork, time in nature; chronic stress worsens sleep and mood

✅ Key point: Conventional and holistic approaches are not mutually exclusive. Many women benefit from a holistic foundation plus FDA-approved bioidentical hormone therapy for troublesome symptoms, not custom-compounded preparations¹⁵. Discuss with a menopause-trained provider.

💊

Conventional / Medical Approach

Low-dose hormonal contraception, MHT (menopausal hormone therapy), SSRIs, gabapentin

First-Line

Low-dose combination oral contraceptive (smooths hormonal fluctuations) or low-dose MHT

Vasomotor Reduction

MHT: about 75% fewer hot flashes than placebo⁷; gabapentin: 45% fewer from baseline versus 29% on placebo¹⁹; some SSRIs, such as paroxetine, also reduce them²⁰

Newer Options

Fezolinetant, a non-hormonal neurokinin-⁠3 receptor antagonist specifically for hot flashes²⁰

Considerations

MHT benefits generally outweigh risks for women with bothersome symptoms who are under 60 or within 10 years of menopause and have no contraindications²¹

Conventional Approach Includes

Bioidentical hormone therapy (estradiol patch + micronized progesterone), FDA-approved, first-line for moderate-to-severe vasomotor symptoms in women under 60 or within 10 years of menopause²¹
Low-dose oral contraceptive, stabilizes erratic cycles, controls bleeding, reduces symptoms in early perimenopause; the combined pill is not recommended from age 50 ⁸
SSRIs/SNRIs (paroxetine, venlafaxine, escitalopram), reduce hot flashes²⁰; useful when mood symptoms coexist
Gabapentin, particularly helpful for night sweats and sleep-disrupting hot flashes
Vaginal estrogen (cream, ring, tablet), local treatment for vaginal dryness and recurrent UTIs; minimal systemic absorption; after breast cancer, NICE notes its effect on recurrence is unknown, so it is a decision to make with the oncology team¹²
Fezolinetant, newest non-hormonal option specifically targeting the hypothalamic mechanism of hot flashes

⚠️ Note: Early reporting of the WHI study (2002) led many women to stop MHT; later analysis by age and time since menopause found a more favorable balance for younger women². NICE advises weighing each person's benefits and risks, including a breast cancer risk with combined hormone therapy that rises with duration of use¹². Current guidance supports MHT for women with bothersome symptoms who are under 60 or within 10 years of menopause, without contraindications²²¹. Discuss with a menopause-trained provider (find one at menopause.org).

Supplement Protocol

Evidence-Based Supplements for Perimenopause

Supplements are not recommended for hot flashes¹⁸; the rows below say what the trials found and what each one is used for.

Supplement	What it is for	Typical range	Timing	Notes & cautions
Magnesium Glycinate	Cofactor for hundreds of enzymes including those involved in neurotransmitter and hormone synthesis. Sometimes used for sleep; a placebo-controlled trial found magnesium did not reduce hot flashes¹⁸.	300 to 400 mg/night	30 to 60 min before bed	Avoid magnesium oxide (laxative, poorly absorbed). No routine test reflects body magnesium stores well. The top of this range is above the 350 mg/day upper intake level for supplemental magnesium; above that, diarrhea is common. With kidney disease, take it only on your clinician's advice.
Black Cohosh	A Cochrane review of 16 trials found no difference from placebo in hot flash frequency¹⁶.	Not recommended for hot flashes (16 trials found no difference from placebo)	Not applicable	Rare cases of liver damage, some very serious, have been reported: stop it and see a clinician for dark urine or unusual fatigue. May not be safe in pregnancy or breastfeeding²³.
Vitex (Chasteberry)	Studied mainly for premenstrual symptoms, where most trials were at high risk of bias; evidence in perimenopause is lacking²⁴.	400 to 500 mg/day (standardized extract)	Morning, away from food	Effect builds over 2 to 3 months. Avoid in pregnancy and breastfeeding, and with breast, uterine or ovarian cancer²⁴. May interact with dopamine agonists.
Omega-⁠3 EPA/DHA	In pooled trials of 899 women, 1.8 g a day did not reduce hot flashes¹⁸.	Not recommended for hot flashes (the trials used 1.8 g a day)	Not applicable	Eat fatty fish such as wild salmon or sardines instead. In heart trials, fish oil supplements raised the risk of atrial fibrillation, an irregular heartbeat, more so above 1 g a day²⁵, so check any fish oil supplement with your clinician first. At higher doses fish oil can increase bleeding risk; tell your clinician if you take a blood thinner or have heavy bleeding.
Vitamin D3 + K2	Vitamin D matters for bone density, and perimenopausal women are commonly deficient.	D3: set the dose with your clinician; most adults need no blood test first; K2 MK-⁠7: 100 to 200 mcg/day	With largest fat meal	If you take warfarin, clear any vitamin K supplement with the clinician managing your anticoagulation before starting or stopping it: vitamin K antagonizes warfarin, and changing your intake destabilizes the INR. Consistency matters more than avoidance. This does not apply in the same way to direct oral anticoagulants such as apixaban or rivaroxaban, but tell your prescriber about any supplement you take.
Ashwagandha	An adaptogen studied for stress. Small trials report less stress and better sleep; rare cases of liver injury have been reported²⁶.	300 to 600 mg/day (standardized root or root-and-leaf extract)	With dinner or before bed	Avoid in pregnancy and breastfeeding, before surgery, and with autoimmune or thyroid disorders²⁶. Best results after 4 to 8 weeks of consistent use.
B-Complex	B6, B12 and folate support neurotransmitter synthesis. B6 has weak evidence for premenstrual symptoms.	B-complex supplying 50 to 100 mg of B6/day	Morning with breakfast	Standard or methylated forms both work for most people. Keep total B6 within the adult upper limit of 100 mg a day, which the top of this range reaches: long-term high doses can cause nerve damage that can be permanent²⁷. In pregnancy, check with your midwife or doctor.
Calcium (food-first, supplement if needed)	Bone density loss accelerates in perimenopause. RDA is 1,000 to 1,200 mg/day. Food sources (dairy, sardines with bones, leafy greens, almonds, tahini) are absorbed and utilized better than supplements. The upper limit is 2,500 mg a day up to age 50 and 2,000 mg from 51, food and supplements together²⁸.	Diet: 1,000 to 1,200 mg total; supplement 300 to 500 mg only if diet insufficient	Split doses with meals if supplementing	Calcium citrate better absorbed than carbonate. Make sure your vitamin D intake is adequate. Don't take with iron or thyroid medications.

References & Evidence Notes

Each numbered entry below is either a source you can follow or a note setting out what the evidence does and does not support. Both are numbered together so the markers in the text line up.

Last reviewed October 20, 2026. Supplement entries are cross-checked against the NIH National Center for Complementary and Integrative Health and the Linus Pauling Institute Micronutrient Information Center.³⁰ Perimenopause is a hormonal transition, not a deficiency to be corrected by supplements, and the most useful fact about it is that the hormonal fluctuation is erratic rather than steadily declining, which is why a one-off blood test so often comes back normal and why women are told nothing is wrong. Hormone therapy is effective for vasomotor symptoms and, for most women starting near the menopause, its benefits outweigh its risks, which is a different message from the one that circulated for twenty years after the initial WHI reporting. That is a conversation worth having with a clinician rather than one to be talked out of. Heavy bleeding that soaks a pad or tampon every 1 to 2 hours, bleeding between periods or any bleeding after 12 months without a period is not perimenopause and needs investigation.

On timing: in the Massachusetts Women's Health Study, which followed about 2,570 women aged 45 to 55 for five years, perimenopause began at a median age of 47.5 and lasted nearly four years, and natural menopause came at 51.3; smokers had an earlier and shorter transition, PubMed 1565019. ↩
On hormone therapy, and the WHI correction: initial reporting from the Women's Health Initiative in 2002 produced a lasting fall in hormone therapy use. Subsequent reanalysis by age and time since menopause found a substantially more favorable balance for women under 60 or within ten years of menopause, PubMed 17405972, and current position statements from major menopause societies reflect that. Risks differ by formulation, route and whether a progestin is required. Transdermal estradiol avoids the first-pass venous thromboembolism risk associated with oral preparations. This is a genuinely individual decision. ↩
On why testing disappoints: FSH and estradiol fluctuate substantially within and between cycles during the transition, so a single measurement cannot establish perimenopausal status in a woman with intact cycles. Diagnosis is clinical, based on age, cycle pattern and symptoms. Being told your hormones are "normal" is frequently a statement about the limits of the test. ↩
On the stages: perimenopause is defined by cycle variability, with the early transition marked by cycle length varying by seven days or more and the late transition by intervals of 60 days or more. Menopause is diagnosed retrospectively after twelve months without a period. Symptoms often begin years before cycles change noticeably. ↩
On the transition and later health: ACOG patient guidance says estrogen output begins to fluctuate in the 30s and 40s, gives 51 as the average age of menopause, advises reporting changes in menstrual bleeding because abnormal bleeding may be a sign of a problem, and notes that bone is lost most rapidly in the first 4 to 8 years after menopause and that the risk of heart attack and stroke rises as estrogen falls and midlife risk factors become more common, ACOG, the menopause years. ↩
On how long hot flashes last: in a US study of 1,449 women with frequent hot flashes or night sweats, the median total duration was 7.4 years, with a median of 4.5 years after the final period; symptoms that began before or early in perimenopause lasted longest, PubMed 25686030. ↩
On how much hormone therapy reduces hot flashes: a 2004 systematic review of 24 randomized placebo-controlled trials with 3,329 women found oral hormone therapy cut weekly hot flash frequency by 75% relative to placebo. Women on placebo also improved, by 57.7% from baseline, which is why any hot flash remedy needs a placebo comparison, PubMed 15495039. ↩
On symptoms, contraception and self-help: NHS guidance notes that a change in periods is usually one of the first signs of perimenopause and that symptoms usually last 7 to 9 years. Pregnancy is still possible, so contraception is needed for 2 years after the final period at ages 40 to 49 and for 1 year at 50 or over, and the combined pill is not recommended from 50. It advises seeing a doctor if bleeding becomes heavier than before and suggests avoiding triggers such as spicy food, caffeine, hot drinks, smoking and alcohol. It advises not smoking and notes that CBT can help hot flashes, low mood, anxiety and sleep, NHS, menopause symptoms and NHS, things you can do. ↩
On smoking: pooled data from 17 studies of 207,231 women found that current smokers had about twice the risk of premature (before 40) and early (40 to 44) menopause, with risk rising with the years smoked; women who had quit more than 10 years earlier had a risk similar to never smokers, PubMed 30481189. ↩
On mood: in 221 women followed through the menopausal transition, major depression was two to four times more likely when they were perimenopausal or early postmenopausal than before, independent of past depression, stressful life events and hot flashes, PubMed 21306662. ↩
On bone and cardiovascular health: bone loss accelerates in late perimenopause and the early postmenopausal years, making calcium and vitamin D adequacy and resistance and impact exercise genuinely important during this window. Cardiovascular risk factors also shift, and this is a reasonable point to have blood pressure and lipids reviewed rather than waiting. ↩
On diagnosis and hormone therapy: NICE guidance identifies perimenopause without blood tests in people aged 45 or over with recent hot flashes and cycle changes, considers an FSH test only at 40 to 45 or under 40, and advises against FSH testing while taking combined hormonal contraception. It recommends offering hormone therapy for hot flashes and considering menopause-specific CBT, discussing each person's benefits and risks, including a breast cancer risk with combined therapy that rises with duration of use, and reviewing treatment at 3 months and then yearly. Bleeding is common in the first 6 months of hormone therapy, and unscheduled bleeding after that needs prompt review. For people with a history of breast cancer, it is unknown whether vaginal estrogen affects recurrence, although the amount absorbed is minimal compared with systemic therapy, NICE NG23. ↩
On early menopause: NHS guidance says early menopause is more likely with a family history, early first periods, smoking or being underweight, and can be caused by radiation therapy, chemotherapy, certain hormone medicines or surgery to remove the ovaries; replacing hormones matters when menopause starts before 45, because of higher risks to bones and heart, unless certain cancers rule hormone treatment out, NHS, early menopause. ↩
On bleeding that needs checking: NHS guidance says any vaginal bleeding after 12 months without a period needs to be checked, even if it happened once or was only spotting, because although it is usually not serious it can be a sign of cancer. It advises seeing a doctor for bleeding between periods or after sex, describes heavy periods as needing to change a pad or tampon every 1 to 2 hours, passing clots larger than about 1 inch (2.5 cm) or bleeding for more than 7 days, and lists fibroids, endometriosis, adenomyosis, bleeding disorders, some medicines and, rarely, uterine cancer among the causes, NHS, postmenopausal bleeding and NHS, heavy periods. ↩
On compounded "bioidentical" hormones: FDA-approved bioidentical hormones exist and are widely prescribed. Custom-compounded preparations, including pellets, are not subject to the same testing for dose consistency, purity or safety, and salivary hormone testing used to guide them is not validated for this purpose. Major menopause societies advise against compounded preparations where an approved equivalent exists. ↩
On supplements for symptoms: evidence for black cohosh, evening primrose and most botanicals is weak and inconsistent, with placebo response high in vasomotor symptom trials; the 2012 Cochrane review of black cohosh, 16 trials in 2,027 perimenopausal and postmenopausal women, found no difference from placebo in hot flash frequency and concluded the evidence is insufficient to support its use for menopausal symptoms, PubMed 22972105. Isoflavones have modest effects at best. Serious harm is rare, although black cohosh has been linked to rare cases of liver damage, and none should displace a discussion about treatments that work. ↩
On soy and red clover: a 2012 meta-analysis of 17 placebo-controlled trials found that soy isoflavone supplements (median 54 mg a day) reduced hot flash frequency by 20.6% and severity by 26.2% more than placebo, with wide variation between trials. A 2013 Cochrane review of 43 trials found no conclusive evidence that phytoestrogen supplements reduce hot flashes, including no significant effect of a red clover extract in five pooled trials, while placebo alone cut hot flashes by 1% to 59%. A 2026 meta-analysis of nine red clover trials found a small to moderate reduction in frequency. The 2023 position statement of the North American Menopause Society does not recommend soy foods or soy extracts for hot flashes, PubMed 22433977, PubMed 24323914, PubMed 42269521, PubMed 37252752. ↩
On supplements for hot flashes: a pooled analysis of three trials in 899 women found no effect of 1.8 g a day of omega-⁠3 on hot flash frequency or bother, and a trial of magnesium oxide in 289 postmenopausal women with a history of breast cancer found no benefit. The 2023 position statement of the North American Menopause Society does not recommend supplements or herbal remedies for hot flashes; the non-hormonal options it recommends are CBT, clinical hypnosis, some antidepressants, an anticonvulsant and a neurokinin-⁠3 receptor blocker, PubMed 26241433, PubMed 25423327, PubMed 37252752. ↩
On gabapentin: in a 12-⁠week randomized placebo-controlled trial in 59 postmenopausal women with seven or more hot flashes a day, gabapentin reduced hot flash frequency by 45% from baseline against 29% on placebo. The trial enrolled postmenopausal rather than perimenopausal women, PubMed 12576259. ↩
On non-hormonal options: cognitive behavioral therapy has evidence for vasomotor symptoms and sleep; certain antidepressants reduce hot flashes; newer neurokinin-⁠3 receptor antagonists are approved for vasomotor symptoms. These matter for women who cannot or prefer not to use hormones. ↩
On who hormone therapy suits: the 2022 position statement of the North American Menopause Society concluded that for women younger than 60 or within 10 years of menopause onset, and without contraindications, the benefit-risk balance favors treating bothersome hot flashes and preventing bone loss, and that it is less favorable when therapy starts more than 10 years after menopause or after 60, PubMed 35797481. ↩
On alcohol and breast cancer: the National Cancer Institute states that women who have just one drink a day have a higher risk of breast cancer than those who have less than one drink a week, and that light drinkers are 1.04 times as likely to develop it, National Cancer Institute, Alcohol and Cancer Risk. ↩
On black cohosh safety: the NIH complementary health center reports rare cases of liver damage, some very serious, in people taking products labeled as black cohosh, advises contacting a clinician for symptoms of liver damage such as dark urine and fatigue, notes that some products contain the wrong herb, and says black cohosh may not be safe during pregnancy or breastfeeding, NCCIH, black cohosh. ↩
On chasteberry: a 2017 meta-analysis of trials in premenstrual syndrome found a large pooled effect, but most trials were at high risk of bias, results varied widely and publication bias was likely, so no definitive conclusion was possible. The NIH complementary health center notes that chasteberry may be unsafe during pregnancy or breastfeeding and may not be safe for women with hormone-sensitive conditions such as breast, uterine or ovarian cancer, PubMed 28237870 and NCCIH, chasteberry. ↩
Gencer B, Djousse L, Al-Ramady OT, Cook NR, Manson JE, Albert CM. Effect of long-term marine omega-⁠3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation. 2021;144(25):1981-⁠1990. PubMed 34612056. Seven trials with 81,210 people followed for about 5 years: omega-⁠3 supplements were linked to a higher risk of atrial fibrillation (hazard ratio 1.25), more so in trials of more than 1 g a day (1.49), and the risk rose with each additional gram. ↩
On ashwagandha safety: the NIH complementary health center notes rare cases linking ashwagandha supplements to liver injury, advises avoiding it during pregnancy and breastfeeding, says it is not recommended before surgery or for people with autoimmune or thyroid disorders, and lists possible interactions with medicines for diabetes, blood pressure, seizures and thyroid disease, sedatives and immunosuppressants, NCCIH, ashwagandha. ↩
On vitamin B6 limits: the US tolerable upper intake level for adults is 100 mg a day, and the European limit is 12 mg a day. Long-term high doses can cause a sensory neuropathy with pain and numbness in the hands and feet that can be irreversible; it usually occurs above 1,000 mg a day, but cases have been reported below 500 mg a day taken over months to years, Linus Pauling Institute, vitamin B6. ↩
On the calcium limit: the tolerable upper intake level for calcium, counting food and supplements together, is 2,500 mg a day for adults aged 19 to 50 and 2,000 mg a day from 51, Linus Pauling Institute, calcium. ↩
On crisis help: NIMH advises anyone struggling or having thoughts of suicide to call or text the 988 Suicide and Crisis Lifeline at 988, and to call 911 in life-threatening situations, NIMH, suicide prevention. ↩
National Center for Complementary and Integrative Health (NIH), nccih.nih.gov, and the Linus Pauling Institute Micronutrient Information Center, lpi.oregonstate.edu/mic. ↩

Cause	How It Contributes to Perimenopause	What Helps
Ovarian aging	As the ovaries age, estrogen output fluctuates, cycles become longer or shorter, periods may be skipped, and they finally stop, at an average age of 51 ⁵	Nothing to correct: care is aimed at symptoms. NICE advises offering hormone therapy for hot flashes and considering menopause-specific CBT¹², as the treatment section describes
Smoking	Current smokers had about twice the risk of premature and early menopause, rising with the years smoked; women who had quit more than 10 years earlier had the same risk as never smokers⁹	Stopping smoking, which the NHS also advises because smoking can make menopause symptoms worse⁸
Surgery and cancer treatment	Removing the ovaries, radiation therapy, chemotherapy and certain hormone medicines can bring menopause on early¹³	Replacing hormones when menopause starts before 45, because of the higher risks to bones and heart, unless a cancer rules hormone treatment out¹³
Family history, early first periods and low weight	Early menopause is more likely if it runs in the family, if periods started early, or in people who smoke or are underweight¹³	Telling your clinician, because age changes the tests: at 45 or over perimenopause is identified from symptoms alone, while an FSH blood test is considered at 40 to 45 or under 40 ¹²
Triggers that worsen hot flashes	Spicy food, caffeine, hot drinks, smoking and alcohol can set off hot flashes and night sweats⁸	The alcohol and caffeine limits in the diet section, a cool bedroom and light clothing, and CBT, which can help hot flashes, low mood and sleep⁸
Other causes of heavy or irregular bleeding	Heavier periods are common near menopause, but fibroids, endometriosis, adenomyosis, bleeding disorders, some medicines and, rarely, uterine cancer also cause them¹⁴	Assessment rather than assuming perimenopause: see When to Seek Care below, and the rule-out tests in the diagnosis section

Test	What it shows
Clinical Diagnosis (Primary)
Symptom & Cycle Tracking	The most reliable diagnostic tool. Track cycle length, flow and symptoms (hot flashes, sleep, mood, energy) daily for 2 to 3 cycles. At 45 or over, recent hot flashes plus any change in the cycle identify perimenopause without blood tests¹².
Basal Body Temperature	Charting morning temperatures reveals whether ovulation is still occurring. Anovulatory cycles (no temperature rise) become more frequent in perimenopause.
Laboratory Tests (Supportive)
FSH & Estradiol	FSH rises and estradiol declines as the ovaries become less responsive, but in early perimenopause, levels fluctuate widely³. A single normal reading does not rule out perimenopause. NICE considers FSH only to confirm menopause at 40 to 45 or under 40, and not while taking combined hormonal contraception¹².
Progesterone (Day 21)	Drawn on cycle day 21 (7 days post-ovulation). Levels <5 ng/mL suggest the cycle was anovulatory, which becomes more common in perimenopause; it is not a test for perimenopause itself³.
Urine Hormone Metabolite Test	Commercial dried urine hormone tests are not validated for diagnosing perimenopause or guiding treatment, and hormones fluctuate too much for a single sample to settle it³¹⁵.
Rule-Out Panel	Thyroid (TSH, free T3, free T4, TPO antibodies), ferritin, vitamin D where deficiency is suspected, B12, HbA1c. Symptoms overlapping with thyroid dysfunction and iron-deficiency anemia are common; rule these out before attributing everything to hormones. Bleeding after menopause, between periods or after sex, or much heavier than before is assessed separately¹⁴.

What to eat or do	Details
✅ Prioritize These:
Ground Flaxseed (2 tbsp/day)	Highest dietary source of lignans (phytoestrogens). Its effect on hot flashes in trials has not been clear. Also rich in fiber and ALA omega-⁠3. Grind fresh; oxidizes quickly.
Cruciferous Vegetables Daily	Broccoli, cauliflower, kale, Brussels sprouts, cabbage. Contain DIM and I3C; claimed effects on estrogen metabolism have not been shown to change symptoms.
Fatty Fish 3x/week	Wild salmon, sardines, Atlantic mackerel, anchovies. A source of EPA/DHA omega-⁠3 fats, useful as heart risk rises after menopause⁵. These are all low-mercury choices.
Protein 30 g per meal	Muscle mass starts declining now. About 0.55 to 0.7 g protein per pound (1.2 to 1.6 g per kg) of body weight, distributed across 3 meals, supports muscle protein synthesis. Especially leucine-rich sources (eggs, chicken, fatty fish, Greek yogurt).
❌ Limit or Eliminate:
Alcohol (Especially Wine)	One of the most potent hot flash triggers. Disrupts sleep architecture even if it helps you fall asleep. Even one drink a day raises breast cancer risk, compared with less than one drink a week²².
Excess Caffeine	Trigger for hot flashes and night sweats. Disrupts already-fragile sleep. Cap at one cup in the morning; switch to green tea or herbal alternatives.
Refined Sugar & Flour	Worth limiting for weight and heart health; that sugar itself triggers hot flashes has not been shown.
Ultra-Processed Meat	Bacon, sausage and deli meats are worth limiting for heart health. Replace with whole-food protein sources.

Perimenopause

What Is Perimenopause?

Stages of Perimenopause

Early Perimenopause

Mid Perimenopause

Late Perimenopause

Perimenopause by the Numbers

Symptoms of Perimenopause

Causes of Perimenopause

How Perimenopause Is Diagnosed

Conventional and Holistic Treatment for Perimenopause

Holistic / Functional Approach

Full Holistic Approach Includes

Conventional / Medical Approach

Conventional Approach Includes

Diet for Perimenopause

Evidence-Based Supplements for Perimenopause

What to Expect Over Time

A Window for Bone, Heart and Metabolic Health

References & Evidence Notes

Perimenopause

What Is Perimenopause?

Stages of Perimenopause

Early Perimenopause

Mid Perimenopause

Late Perimenopause

Perimenopause by the Numbers

Symptoms of Perimenopause

Causes of Perimenopause

How Perimenopause Is Diagnosed

Conventional and Holistic Treatment for Perimenopause

Holistic / Functional Approach

Full Holistic Approach Includes

Conventional / Medical Approach

Conventional Approach Includes

Diet for Perimenopause

Evidence-Based Supplements for Perimenopause

What to Expect Over Time

Related Conditions

A Window for Bone, Heart and Metabolic Health

References & Evidence Notes